Tooth extraction often leads to alveolar bone resorption, negatively affecting future prosthetic or implant rehabilitation. Socket preservation techniques have been introduced to minimize post-extraction bone loss, with biomaterials such as xenografts commonly used to maintain bone volume. Though graft materials can reduce alveolar bone resorption, grafted sites often have poor vascularization and nonvital residual particles which can negatively affect the bone to implant contact. A combination of autologous platelet concentrates with the graft which will  improve the percentage of new bone formation Recently, injectable platelet rich fibrin has gained attention for its potential to enhance wound healing and bone regeneration due to its sustained release of growth factors. However, research on the combined use of injectable platelet-rich fibrin and xenografts for socket preservation remains limited. This study evaluates the clinical, radiographic, and histological outcomes of socket preservation using injectable platelet-rich fibrin , xenograft, and a resorbable membrane, compared to xenograft with a resorbable membrane and unassisted healing. Clinical parameters, including the gingival index and wound healing index, will be evaluated. Vertical and horizontal ridge width measurements will also be assessed using a digital caliper. Additionally, radiographic measurements using CBCT imaging will be performed to evaluate horizontal and vertical ridge dimensions, buccal plate thickness, and bone density. Histologic analysis after six months will assess new vital bone formation, connective tissue, and residual bone graft. Sample size calculated using the mean and SD of the loss of ridge height in the three groups from previous study ,is 15 per group . Patients will be randomly assigned to one of three groups using a permuted block randomization fixed  method and allocation concealment by sequentially numbered sealed opaque envelops. Group 1 will receive socket preservation with xenograft, membrane, and injectable platelet-rich fibrin. Group 2 will receive xenograft and membrane  and  the control group will undergo unassisted healing. Clinical and radiographic parameters will be recorded after 6 months and the outcome assessor will be blinded. This comprehensive evaluation aims to determine the effectiveness of socket preservation using injectable platelet-rich fibrin and xenograft in maintaining ridge dimensions and increase in amount of vital bone and reduction in residual graft material there by promoting bone regeneration for future implant placement.